Chapter

Exploring the Differences in Psychedelic Assisted Therapy with Psilocybin and Ketamine
listen on SpotifyListen on Youtube
14:25 - 27:42 (13:17)

This episode talks about the differences in the therapeutic approaches between psilocybin and ketamine assisted therapy and the lack of studies that have compared the two. The guest highlights the importance of addressing root narratives leading to depression for long term antidepressant effects, which has been studied more with psilocybin than ketamine.

Clips
A discussion on the differences in durability between ketamine and psilocybin as antidepressant treatments, as well as the potential for lasting effects with the latter due to its ability to address underlying narratives that lead to depression.
14:25 - 20:09 (05:43)
listen on SpotifyListen on Youtube
Psychedelics
Summary

A discussion on the differences in durability between ketamine and psilocybin as antidepressant treatments, as well as the potential for lasting effects with the latter due to its ability to address underlying narratives that lead to depression.

Chapter
Exploring the Differences in Psychedelic Assisted Therapy with Psilocybin and Ketamine
Episode
#619: Dr. Suresh Muthukumaraswamy — LSD Microdosing, Classical Psychedelics vs. Ketamine, Science and Speed in New Zealand, Placebo Options, and The Infinite Possibilities of Studying Mind-Altering Compounds
Podcast
The Tim Ferriss Show
This podcast discusses the differences between the studies done on psilocybin and ketamine assisted therapy and the ethical issues that arise when trying to find a balance between the two.
20:09 - 24:22 (04:13)
listen on SpotifyListen on Youtube
Psychedelic therapy
80 healthy volunteers participated in a six-week LSD microdosing study where they took the first dose in the laboratory and the other 13 doses were taken outside of the laboratory setting.
24:22 - 27:42 (03:20)
listen on SpotifyListen on Youtube
LSD microdosing
Summary

80 healthy volunteers participated in a six-week LSD microdosing study where they took the first dose in the laboratory and the other 13 doses were taken outside of the laboratory setting. Participants underwent multiple screening sessions before being allowed to participate in the study.

Chapter
Exploring the Differences in Psychedelic Assisted Therapy with Psilocybin and Ketamine
Episode
#619: Dr. Suresh Muthukumaraswamy — LSD Microdosing, Classical Psychedelics vs. Ketamine, Science and Speed in New Zealand, Placebo Options, and The Infinite Possibilities of Studying Mind-Altering Compounds
Podcast
The Tim Ferriss Show